Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
P10 Inc has a consensus price target of $13.56 based on the ratings of 9 analysts. The high is $21 issued by Oppenheimer on December 12, 2024. The low is $10 issued by Keefe, Bruyette & Woods on March 1, 2024. The 3 most-recent analyst ratings were released by Oppenheimer, Barclays, and JP Morgan on December 12, 2024, December 9, 2024, and November 12, 2024, respectively. With an average price target of $16.67 between Oppenheimer, Barclays, and JP Morgan, there's an implied 29.30% upside for P10 Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for P10 (NYSE:PX) was reported by Oppenheimer on December 12, 2024. The analyst firm set a price target for $21.00 expecting PX to rise to within 12 months (a possible 62.92% upside). 22 analyst firms have reported ratings in the last year.
The latest analyst rating for P10 (NYSE:PX) was provided by Oppenheimer, and P10 maintained their outperform rating.
There is no last upgrade for P10
The last downgrade for P10 Inc happened on August 21, 2024 when UBS changed their price target from $10 to $10.5 for P10 Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of P10, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for P10 was filed on December 12, 2024 so you should expect the next rating to be made available sometime around December 12, 2025.
While ratings are subjective and will change, the latest P10 (PX) rating was a maintained with a price target of $17.00 to $21.00. The current price P10 (PX) is trading at is $12.89, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.